AzTrials
AzTrials

Heart Failure,CongestiveADHFQUAL-BFHNCT06176131

The Cardio-share Telemedicine Cross-sector Collaboration Model for Managing Vulnerable Patients With Heart Failure

An observational study of Heart Failure,Congestive and Atrial Fibrillation, run by University Hospital Bispebjerg and Frederiksberg at 1 site in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to explore the potential of implementing a telemedicine-based cross-sector collaboration model to manage patients with frequent admissions with decompensated heart failure. Read more about this study

Who is it for?
Any age
What is being tested?
Telemedicine-based cross-sector collaboration for patient management
How many people
300 participants
Where
1 siteDenmark
Study dates
1 Jan 2024to 31 Dec 2026
How long will I take part?
6 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients admitted to the University Hospital of Bispebjerg and Frederiksberg and for whom this is their reference hospital for general heart conditions.

Who may be able to join

  • Patients admitted with acute decompensated heart failure AND:
  • with previous admission with decompensated heart failure in the three-month period prior to the current admission or
  • who have two or more admissions in the 6 months prior to the current admission.

Who cannot join

  • Patients who
  • have refused to share their data for health-quality projects
  • have already ongoing telemedicine management for heart failure

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Helena DOMINGUEZ, MD,PhD,Prof contact

004522989343

mdom0002@regionh.dk

Ida Gustafsson, MD, PhD contact

004521778226

ida.gustafsson@regionh.dk

Denmark1 site, 1 recruiting
  • Cardiology department Y, Bispebjerg-Frederiksberg Hospital

    Frederiksberg, 2000

    Helena Dominguez, MD, PhD, +4538163916 ext. 6068, mdom0002@regionh.dk

    Christoffer V Madsen, MD, +4520661178, cmad0140@regionh.dk

    Recruiting

Other trials in Denmark

About this study

Official title: Implementering af Cardiostafet tværsektoriel Samarbejdsmodel Med Telemedicin for Udsatte Patienter Med Hjertesvigt Som Ikke Kan Deltage i Hjerterehabilitering

The goal of this observational study is to explore the potential of implementing a telemedicine-based cross-sector collaboration model to manage patients with frequent admissions with decompensated heart failure. The main question(s) it aims to answer are:

  • Characterization of conditions that make these patients vulnerable
  • Description of key-elements that makes possible to manage the patients with the cardio-share model
Read more

Participants are:

  • Patients - will be helped to use the available telemedicine tools
  • General Practitioners - will be offered teleconferences with cardiologists (chat and video) on demand
  • Community health workers (caregivers at the patient home or in elderly home) - will be guided to assist the patients to use the available telemedicine tools Researchers will compare readmission rates (primary outcome) and quality of life of patients where the cardio-share management model is successfully implemented one year before and after the implementation.
Read the detailed description

Consecutive patients admitted from 01.01.2024 to one single site (University Hospital Bispebjerg and Frederiksberg) with acute decompensated heart failure or with atrial fibrillation treated with loop-diuretics will be included in the project if they had one emergency admission with decompensated heart condition within the prior 3 months or two or more within the prior 6 months.

During their hospital admission patients will be helped to use the currently available telemedicine tools, which is "Min Sundhedsdplatformen Assistent" (MinSP-Ass.), which is the Danish version of the Care Companion-extension of MyChart application by EPIC, which is the platform used in East Denmark. Help is provided by the nurses in the ward, with assistance by medicine students working on a pay-per-hour basis.

The cardio-share model briefly If it is planned or the patient already is receiving home-care assistance (either at home or at an elderly home), the health-care workers will be contacted to ensure that they can assist the patient to use MinSP-Ass.

Likewise, the general practice where the patient belongs to, will be contacted to offer teleconsultation support by the hospital-based cardiologist. This support is primarily by written messages, and by teleconferences on demand (from Primary Care) before patient discharge, in both cases using MedCom standards, which is the current cross-sector communication platform in Denmark.

Through MinSP-Ass. patients can receive educational material and can report vital measurements and symptoms.

The responsibility of the management of the patient relays in the hospital cardiologist who initiates the cardio-share management. A script for a seamless switching of this responsibility between the cardiologist team and Primary Care will be developed and described throughout the project. This will include solving data-sharing across sectors since there are no current solutions easy to use for this purpose.

Data collection The electronic medical record will be explored retrospectively to record data at three time-points: After discharge (Baseline), three and six months after admission.

At baseline there will be recorded: i) demography data, ii) selected vital measurements and laboratory data and iii) heart medicines.

At month three there will be recorded whether there has been at least one readmission and the date of the first readmission and if the patient has had visits in the cardiology ambulatory. At month six there will be recorded whether there have been one or more readmissions and the date of the first readmission if it occurred after month 3.

Demography data will be collected according to the following conditions that may render the patient vulnerable:

  • Speaking Danish language
  • Cognitive challenges described in the medical record
  • Need for help from health community workers or relatives for their daily life
  • Psychiatric disease (ongoing follow-up)
  • Substance abuse (alcohol or drugs)

At baseline and at month 6 there will be recorded:

  • Selected vital measurements, which include blood pressure, heart rate and weight
  • Laboratory data, which include hemoglobin, creatinine and pro-Brain Natriuretic Peptide (pro-BNP)
  • Prescription and use of heart medicines
Being tested
Telemedicine-based cross-sector collaboration for patient management
Keywords
heart failure, atrial fibrillation, acute decompensated heart failure, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction, telemedicine, health inequity, cross-sector health management
Medical subject headings
Heart Failure, Atrial Fibrillation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Telemedicine-based cross-sector collaboration for patient managementOther

    Telemedicine support from the hospital-based cardiology heart-failure team is provided on demand defined by the needs from Primary Care and from the patient rather than plain guideline-based targets

Study groups in NCT06176131
Study groupRoleWhat they receive
cardio-sharePatients with successful cardio-share model fulfill at least one of the following: 1. A plan for follow-up after discharge established, based on communication with Primary Care (home-care and/or General Practice) before discharge 2. The patient has accessed MinSP-Ass. and received information on heart failure 3. The patient has sent vital measurements and symptoms through MinSP-Ass. to the hospital cardiologist
Receives: Other: Telemedicine-based cross-sector collaboration for patient management
OthersAll others who fulfill the inclusion criteria but none of the three elements have been successful are the comparative group "Others"

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Days out-of-hospital

    Number of days out of hospital from date of discharge for the index event until the next re-admission with acute decompensated heart failure

    Measured: six months

Secondary outcomes (3)
  1. Number of readmissions

    number of emergency readmissions after discharge from the index readmission, where there have been signs of decompensated heart failure

    Measured: six months

  2. Quality of care - Medicines

    Proportion of guideline-based target medicines for heart failure that patients actually use (based on purchased medicine prescriptions). This includes angiotensin converter enzyme inhibitors(ACEi)/angiotensin receptor blockers (ARB), Betablockers, Mineralocorticoids, Angiotensin Receptor Neprilysin inhibitors (ARNi), Selective Sodium Glucose Co-Transporter-2 inhibitors (SGLT2i), Hydralazine and Nitrates.

    Measured: six months

  3. Symptom-based quality of care

    Progression of heart failure specific patient-reported outcome measures. These include weekly to monthly collected: • Out-of-breath in daily activities • Night orthopnea • Dizziness • Feeling body fluid retention (leg swelling, increased abdominal pressure, increased intake of diuretics • Tiredness • Feeling of general worsening

    Measured: six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2023
  2. Study start1 Jan 2024
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT06176131
Sponsor's protocol ID
WorkZone-23072092
Acronym
ADHFQUAL-BFH
Status last verified
Jan 2026
First submitted
10 Dec 2023
Last updated
16 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Heart Failure,Congestive and Atrial Fibrillation, run by University Hospital Bispebjerg and Frederiksberg at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Helena DOMINGUEZ, MD,PhD,Prof (004522989343, mdom0002@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Days out-of-hospital (time frame: six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in